Publication | Closed Access

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Hematological MalignancyDose-dense Rituximab-chopStandard Rituximab-chopLymphoid NeoplasiaElderly PatientsMedicineImmunotherapyOncologyRadiation Oncology